Durvalumab vs Phenytoin

Durvalumab vs Phenytoin: Overview

This comparison examines the pharmacological differences between Durvalumab and Phenytoin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Phenytoin: Sodium channel blocker stabilizing inactive state.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Phenytoin — 22 hours.

Chemical Properties

Molecular Formula: Phenytoin — C15H12N2O2.

Molecular Weight: Phenytoin — 252.2680 g/mol.

Type: Durvalumab — Antibody; Phenytoin — Small molecule.